Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe cost of semaglutide pills in the UK varies by provider, and any legitimate price covers a clinical assessment and prescription — not just the tablets. As of summer 2026, Wegovy tablets are the only oral semaglutide medicine licensed in the UK for weight management, approved by the MHRA on 11 June 2026. They are a prescription-only medicine, which means a qualified prescriber must assess your suitability before any supply can take place. The figure you see advertised tells you less than the full picture of what is (and is not) included.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The biggest misconception around semaglutide pill pricing is that the number shown on a website is the number you pay. In private weight-loss care, that is rarely the case. Many providers charge separately for the initial consultation, the prescription, and delivery — costs that can add up quickly across a multi-month treatment course. Some also require a monthly membership before you can even book an assessment. Others price the starter dose cheaply and increase the figure substantially at higher doses, without making that progression obvious upfront.
This matters because Wegovy tablets follow a titration schedule: you begin at 1.5mg, move through 4mg and 9mg, and reach the 25mg maintenance dose over several months, with at least four weeks at each level per clinical guidance. A price that only reflects the first pen or the lowest dose is not a reliable guide to what you will spend. When comparing providers, the honest question is: what does the full cost cover, at every dose level, including clinical oversight and delivery?
You can read more about how Wegovy pill pricing is structured across the titration pathway to get a clearer comparison basis.
Because Wegovy tablets are a prescription-only medicine, every lawful supply requires a prescriber's assessment. That clinical step is not optional, and it should not be invisible in the price. Legitimate providers will build in a consultation, a prescription, and some form of ongoing clinical oversight, particularly at dose increases, where the prescriber needs to confirm that escalation is appropriate.
Delivery is another variable. Same-day or next-day tracked delivery with a reliable courier costs more than standard postage, and a provider absorbing that cost rather than adding it at checkout is absorbing a real expense. Aftercare (a human to contact if you experience side effects or have questions about your tablets) is a further cost that budget providers often strip out.
At nume, one transparent price covers the consultation, prescription, treatment, free next-working-day DPD delivery in plain unbranded packaging, and priority aftercare seven days a week. We are not competing to be the cheapest option on the market, and that is a deliberate position. The MHRA's approval announcement for Wegovy tablets is worth reading if you want the regulator's own framing of what appropriate supply looks like, see the GOV.UK guidance on MHRA semaglutide approvals for context on UK licensing standards.
For a side-by-side look at what different cost structures typically include, the oral semaglutide cost breakdown covers this in more detail.
A small saving on a weight-loss tablet is not a saving if what arrives is counterfeit, unlicensed, or dispensed without proper clinical assessment. The MHRA has a reporting route for suspect sellers, and their public warnings have flagged repeated seizures of fake weight-loss medicines sold online. Some counterfeit products have contained dangerous substitutes. The risk is not theoretical.
Semaglutide pills require not just a prescription but an ongoing clinical relationship. The prescriber needs to know how you are tolerating each dose before you increase. They need to know about any other medicines you take (particularly oral contraceptives, since absorption of both can be affected) and any relevant health changes. That review is where safety lives, and it is not compatible with the cheapest-at-any-cost model.
Price is a reasonable consideration. It is just not the most important one for a prescription medicine where the supply chain, the clinical oversight, and the regulatory registration of the dispensing pharmacy all carry direct consequences for your health. You can verify any online pharmacy's registration on the GPhC pharmacy register, our registration number is 9012878. Worth checking for any provider you are considering.
If you are ready to explore whether Wegovy tablets are clinically suitable for you, the next step is a free consultation with our prescribers. There is no charge to find out. Check your eligibility and start your free consultation.
Questions about the wider tablet options and how oral semaglutide compares to the injection? The semaglutide tablets cost guide sets out the pricing differences across formats. You can also visit how much semaglutide pills cost for a plain-English answer to the core question, and if you want to understand what drives semaglutide tablet cost at a granular level, that page breaks down the individual components clearly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.